{"as_of":"2026-08-18T00:51:00Z","caps":{"database_statements":6,"inbound":100,"outbound":100},"context_digest":"sha256:49793b2748ca2ff34b15c01d11a2495deb6186c380a03002e55fe2ea25edbb99","coverage":[{"denominator":57,"lane":"reference_resolution","note":"Typed states for the displayed outbound observations.","records_observed":57,"source":"paper_references, paper_reference_links","source_observed_at":"2026-08-05T14:25:31.339421Z","state":"measured"},{"denominator":58,"lane":"standing_notices","note":"One-hop event checks from named stored sources.","records_observed":58,"source":"scholarly_work_events, retraction_status_cache","source_observed_at":"2026-08-17T06:30:58.91139+00:00","state":"measured"},{"denominator":1,"lane":"inbound_itemization","note":"Pith citing papers itemized under the disclosed page cap.","records_observed":1,"source":"paper_references, paper_reference_links","source_observed_at":"2026-06-28T15:56:09.312666Z","state":"measured"},{"denominator":1,"lane":"external_citation_measurements","note":"A source-named dated measurement, never combined with another source.","records_observed":0,"source":"arxiv_reference","source_observed_at":"2026-07-01T21:56:16.227901Z","state":"measured"}],"external_citation_measurements":[],"inbound":[{"citation":{"cited_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"cited_work":{"arxiv_id":"2508.21468","doi":null,"metadata_source":"arxiv_reference","pith_arxiv_id":"2508.21468","snapshot_observed_at":"2026-07-01T21:56:16.227901Z","title":null,"venue":null,"work_id":"263c8734-fe74-4b8b-bf4f-949a01d107f7","year":2025},"citing_paper":{"arxiv_id":"2606.01595","last_updated":"2026-06-01T02:48:22Z","snapshot_observed_at":"2026-08-13T16:50:48.304763Z","submitted_at":"2026-06-01T02:48:22Z","title":"Uncertainty-Calibrated Diffusion for Reliable 3D Molecular Graph Generation","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-06-28T15:56:09.312666Z"},"links":{"cited_paper":"/paper/2508.21468","citing_paper":"/paper/2606.01595"},"observation_digest":"sha256:39fbc0c2efde45e0b11c52335419a9da64fbe5e07a59a07d8bc45454c1d4e202","observation_id":"d5d78610-e890-4564-870e-e67b5c4030ad","resolution":{"observed_at":"2026-07-01T21:56:16.229264Z","resolver_source":"arxiv_id","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}}],"links":{"evidence":"/evidence","html":"/paper/2508.21468/citation-record","integrity":"/paper/2508.21468/integrity","json":"/paper/2508.21468/citation-record.json","paper":"/paper/2508.21468"},"outbound":[{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:26.514834Z","title":"Accurate structure prediction of biomolecular interactions with alphafold 3","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":1,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:26.514834Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:d9f445643788a0726802887a14482bae76883b6be80ab48554547bc110cbad32","observation_id":"a3d9517c-6948-408d-8383-7af5eb2e1754","resolution":{"observed_at":"2026-08-05T14:25:26.514834Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.918426Z","title":"Protein sequence modelling with bayesian flow networks","venue":null,"work_id":"4774c733-26a4-4ad6-b8ad-d33c7b9c8596","year":2025},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":2,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:26.556675Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:578d81f4a4c675d1fef8a1c5e58ca26ec0adf4dbd9509af13d659310c1f9309c","observation_id":"4bacf021-a84d-40a9-9ea6-43e7e510f6ef","resolution":{"observed_at":"2026-08-05T14:25:35.922485Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.907164Z","title":"Geometric deep learning methods and applications in 3d structure-based drug design","venue":null,"work_id":"15fcd7f7-8f24-486e-8f67-610395261382","year":2024},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":3,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:26.619168Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:6e2a903e03d43a7fb4dabfae19f1259533cf39d4e9a42dbb85de0178272b05b7","observation_id":"3c3e4d77-9c29-4f60-b393-0b2981d5b957","resolution":{"observed_at":"2026-08-05T14:25:35.910875Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2209.15408","last_updated":"2023-03-01T03:23:32Z","snapshot_observed_at":"2026-08-16T16:27:51.894033Z","submitted_at":"2022-09-30T12:10:15Z","title":"Equivariant Energy-Guided SDE for Inverse Molecular Design","version":3},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2209.15408","snapshot_observed_at":"2026-08-05T14:25:26.697348Z","title":"Equivariant energy-guided sde for inverse molecular design","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":4,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:26.697348Z"},"links":{"cited_paper":"/paper/2209.15408","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:92528a75c02026affbe5b8a246529598d93baaabe800493dcf6ef36790e03965","observation_id":"318f2416-f1ab-4dc7-a27b-fe65ae3fcb43","resolution":{"observed_at":"2026-08-05T14:25:26.697348Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.895880Z","title":"Posebusters: Ai-based docking methods fail to generate physically valid poses or generalise to novel sequences","venue":null,"work_id":"b85829cf-0907-4f6b-a654-ae3013f23c1d","year":2024},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":5,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:26.763247Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:4e380bae17adb7be40d84722cd38b9d54c46b0e669de3f1a47b67e1d9d613a7c","observation_id":"b6f900e0-c1be-483d-9404-e370738b467c","resolution":{"observed_at":"2026-08-05T14:25:35.899307Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.884653Z","title":"Pid- iff: Physics informed diffusion model for protein pocket-specific 3d molecular generation","venue":null,"work_id":"241cd93d-5bb2-4aa1-a276-fdce09d22d74","year":2024},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":6,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:26.841297Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:82fa3c37fd096962a3284408381180e521d5c3b3d00d2659f42cdc50742e4acd","observation_id":"98ef91fa-49af-4542-ba35-b0d28b6a0347","resolution":{"observed_at":"2026-08-05T14:25:35.888082Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.873101Z","title":"Diffusion posterior sampling for general noisy inverse problems","venue":null,"work_id":"9abc64c3-df4a-4edc-af3e-b74c29c0c189","year":null},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":7,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:26.929990Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:f0de0d429e346405507ed3e124108dabcf71c38b03365b07a5effde2451f1bc5","observation_id":"179abc6c-775e-479d-be29-aaa145361f06","resolution":{"observed_at":"2026-08-05T14:25:35.877398Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.862250Z","title":"Uniprot: a worldwide hub of protein knowledge","venue":null,"work_id":"304bc400-9685-47b7-b09a-f6dec310d09b","year":2019},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":8,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.024445Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:6592a7eda83e0fd87879170eb995b07bad88447e8d93d256724068a88d1ddcce","observation_id":"af2d385f-5358-4730-b16c-36437d9eadde","resolution":{"observed_at":"2026-08-05T14:25:35.865764Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.851797Z","title":"Multi-parameter optimization: identifying high quality compounds with a balance of properties","venue":null,"work_id":"012be279-4b77-41a2-ad65-92a408c03653","year":2012},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":9,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.089396Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:c9fd284c89688b2a939418e20c095cb4330b5a3258ff3880ddedea57fa6fe866","observation_id":"c0fac689-af22-4d48-a0e8-9f515df84aca","resolution":{"observed_at":"2026-08-05T14:25:35.855286Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:27.169773Z","title":"Comprehensive analysis of kinase inhibitor selectivity","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":10,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.169773Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:94b07c081907c15e7a2265add2dd512c43f780f63a5ea78b8f8448e7bdc0e927","observation_id":"0e59f98b-a02c-401a-a85e-691f2e72b2bf","resolution":{"observed_at":"2026-08-05T14:25:27.169773Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:27.249667Z","title":"Diffusion models beat gans on image synthesis","venue":null,"work_id":null,"year":2021},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":11,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.249667Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:eaacf8b8e776818f5ca0da8a3703bf37f5f9e2a4c0fa7637259aaaa700e7957e","observation_id":"c7ffd768-1954-40ef-875c-57ba0bdf8751","resolution":{"observed_at":"2026-08-05T14:25:27.249667Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.827143Z","title":"Autodock vina 1.2","venue":null,"work_id":"1c8636ae-b982-425d-bddb-479dbfc78f33","year":2021},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":12,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.314201Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:c312bca041c1faf3595fe0c6460597eefc344fadf01e469ea421218e1ea5d379","observation_id":"3ab3b6be-f575-469d-9570-4c93c09096df","resolution":{"observed_at":"2026-08-05T14:25:35.830458Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:27.398826Z","title":"Tweedie’s formula and selection bias","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":13,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.398826Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:d6455c1f42285b2a063cace7483784410cf5cc51cf66ea8cb4c8d73267871c3e","observation_id":"3de22a8b-2936-4993-9244-d8ede7f5e13b","resolution":{"observed_at":"2026-08-05T14:25:27.398826Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.809033Z","title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","venue":null,"work_id":"1f74f0bf-3079-4d0b-b067-e2487606b143","year":2009},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":14,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.486828Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:69e9571fd8c1310aff6d2e8ec69e7d753eee14243520aca272303f198a61cdc3","observation_id":"c622c464-ec52-495b-8f13-9ebf3428af75","resolution":{"observed_at":"2026-08-05T14:25:35.812408Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.798420Z","title":"Three-dimensional convolutional neural networks and a cross- docked data set for structure-based drug design","venue":null,"work_id":"16ebb3a5-21d8-45ce-82cf-7cf3afcaa938","year":2020},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":15,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.553098Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:b6d92238473de5174c919ca88517e45d6461597b0715b61a93b69e8800e6a751","observation_id":"bff8ed79-5779-4a2b-ae68-5aabff2e0276","resolution":{"observed_at":"2026-08-05T14:25:35.801989Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.787945Z","title":"Reinforced genetic algorithm for structure-based drug design","venue":null,"work_id":"a150390c-b47b-44d1-bb7f-f79dbc6f6b76","year":2022},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":16,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.630009Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:36bdd56b840c8c0aae3acf7bbd31d81cecfd74a4a68fa166e8b797e272f96be1","observation_id":"4c77817e-4aab-46b8-a2e1-7ca8182d21d2","resolution":{"observed_at":"2026-08-05T14:25:35.791132Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2403.12987","last_updated":"2024-03-04T07:40:25Z","snapshot_observed_at":"2026-08-16T14:13:12.350486Z","submitted_at":"2024-03-04T07:40:25Z","title":"Rethinking Specificity in SBDD: Leveraging Delta Score and Energy-Guided Diffusion","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2403.12987","snapshot_observed_at":"2026-08-05T14:25:27.708522Z","title":"Rethinking specificity in sbdd: Leveraging delta score and energy-guided diffusion","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":17,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.708522Z"},"links":{"cited_paper":"/paper/2403.12987","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:e0d3fab1e7826ef6cdaa0ffd6b76a1ccb5b1c11ef91d9c4db716bea601bb3569","observation_id":"46b43fad-9298-4ff8-82d9-b140a20dca0f","resolution":{"observed_at":"2026-08-05T14:25:27.708522Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2308.07037","last_updated":"2025-03-11T08:07:39Z","snapshot_observed_at":"2026-08-16T15:08:42.054500Z","submitted_at":"2023-08-14T09:56:35Z","title":"Bayesian Flow Networks","version":6},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2308.07037","snapshot_observed_at":"2026-08-05T14:25:27.775723Z","title":"Bayesian flow networks","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":18,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.775723Z"},"links":{"cited_paper":"/paper/2308.07037","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:621e67faa3bd12492967595d444bb470a0f217eda3cc2922d254447df4014844","observation_id":"5ca183c5-1d0b-49a6-9a86-257db7286feb","resolution":{"observed_at":"2026-08-05T14:25:27.775723Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.778174Z","title":"Aligning target-aware molecule diffusion models with exact energy optimization","venue":null,"work_id":"0bfbc777-2e57-4b3e-b1a8-4ce0567a3b2d","year":2024},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":19,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.893286Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:897fa7835a8cf05a796d4bbe88d60a5331867d7face6117c94eaac91f91263eb","observation_id":"7e09d8f5-750d-4f95-8920-39a1015a8a24","resolution":{"observed_at":"2026-08-05T14:25:35.781390Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2303.03543","last_updated":"2023-03-06T23:01:43Z","snapshot_observed_at":"2026-08-16T15:50:18.551454Z","submitted_at":"2023-03-06T23:01:43Z","title":"3D Equivariant Diffusion for Target-Aware Molecule Generation and Affinity Prediction","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2303.03543","snapshot_observed_at":"2026-08-05T14:25:27.970113Z","title":"3d equivariant diffusion for target-aware molecule generation and affinity prediction.arXiv preprint arXiv:2303.03543, 2023","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":20,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:27.970113Z"},"links":{"cited_paper":"/paper/2303.03543","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:1c5aa523a059fb6b6511e42a0956a54a50c5091401c5af772ab5846e99805b3b","observation_id":"a3d6ecd8-53b9-496b-b6e8-8a0fdb310be9","resolution":{"observed_at":"2026-08-05T14:25:27.970113Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2403.07902","last_updated":"2024-02-26T05:21:21Z","snapshot_observed_at":"2026-08-16T14:15:26.771213Z","submitted_at":"2024-02-26T05:21:21Z","title":"DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2403.07902","snapshot_observed_at":"2026-08-05T14:25:28.012501Z","title":"Decompdiff: diffusion models with decomposed priors for structure- based drug design","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":21,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:28.012501Z"},"links":{"cited_paper":"/paper/2403.07902","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:015e021741d3c6e969f099ac2f61cf4698bb571b9cc855b082bcc228a5306e15","observation_id":"9feb90b4-d6d5-4e3b-bcb0-1fcb0e07f3b5","resolution":{"observed_at":"2026-08-05T14:25:28.012501Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":{"arxiv_id":"2404.14743","last_updated":"2024-10-15T19:37:51Z","snapshot_observed_at":"2026-08-16T13:58:39.931992Z","submitted_at":"2024-04-23T04:51:02Z","title":"Gradient Guidance for Diffusion Models: An Optimization Perspective","version":2},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2404.14743","snapshot_observed_at":"2026-08-05T14:25:28.120881Z","title":"Gradient guidance for diffusion models: An optimization perspective","venue":null,"work_id":null,"year":2024},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":22,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:28.120881Z"},"links":{"cited_paper":"/paper/2404.14743","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:ea14c83655e8abeda020e4dffc6e82680ad19ecd203ac8ccfde6704218719cae","observation_id":"a5feea8d-7175-412c-8958-6aea03dbb2fa","resolution":{"observed_at":"2026-08-05T14:25:28.120881Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.767910Z","title":"Training- free multi-objective diffusion model for 3d molecule generation","venue":null,"work_id":"179051d6-9e24-4b80-aae3-e2268e69a38c","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":23,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:28.182243Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:c9257967e28d1d7bd620db2384395bcd08de437f207570b81af09a7d8311a35e","observation_id":"2060369a-838e-4dec-addc-4ecf849b793b","resolution":{"observed_at":"2026-08-05T14:25:35.771796Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.756560Z","title":"Posecheck: Generative models for 3d structure-based drug design produce unrealistic poses","venue":null,"work_id":"67ee5cd0-3310-48f7-b0dd-fb0c2f9d504e","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":24,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:28.248770Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:231d78839ffb79a518acd71e38baa88726600b84d7de3238bee0fc4654a7e7e0","observation_id":"a9931f27-b7e7-4b53-a45f-e4ee13bdd8e7","resolution":{"observed_at":"2026-08-05T14:25:35.760442Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.746052Z","title":"Protein-ligand interaction prior for binding- aware 3d molecule diffusion models","venue":null,"work_id":"7d55a501-7667-46fb-89fb-734697263aae","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":25,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:28.344035Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:3e9a77bab8531de94f566ae191efb0c463c2adacef2ae68dd9b0b4240bbd5326","observation_id":"5057ed33-0ed7-42bc-8f74-c7608534345a","resolution":{"observed_at":"2026-08-05T14:25:35.749542Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.735198Z","title":"Rational approaches to improving selectivity in drug design","venue":null,"work_id":"c157effe-0815-4889-a3b5-2dc2cfc6580b","year":2012},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":26,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:28.479751Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:6db79db87f60985c36aa9cf8d62e60746ea87c231827498763ab8b5ac33a3356","observation_id":"f95ea69a-eb56-4cd1-9aad-f8871d8cf413","resolution":{"observed_at":"2026-08-05T14:25:35.739050Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.721674Z","title":"A quantitative analysis of kinase inhibitor selectivity","venue":null,"work_id":"648cf723-8734-4e79-913c-55ae588113a5","year":2008},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":27,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:28.561654Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:2e6e7ab17f6204297acf3df3cbe0d267e28143be168814413142cff25ef11ff5","observation_id":"dfb58398-b767-4cc3-b3ca-7dd20043e546","resolution":{"observed_at":"2026-08-05T14:25:35.726398Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.710771Z","title":"Noise2score: tweedie’s approach to self-supervised image denoising without clean images","venue":null,"work_id":"fae284cd-b846-4483-a573-d4a22d861994","year":2021},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":28,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:28.686863Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:1bcff354f8cfb945eedc638d28716f23aada0a8fd5ea211764ecbbc8fd636b8a","observation_id":"417424e6-728b-4418-a579-dab5d851a69b","resolution":{"observed_at":"2026-08-05T14:25:35.714270Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.700615Z","title":"Recent developments in structure-based drug design","venue":null,"work_id":"429736da-c9e7-4adf-8dca-17e39e700e1f","year":2000},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":29,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:28.816716Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:cc6524aa0391fc26ffe12e54fa760bfd63a424b2a9356b21d0feaf04a38a231f","observation_id":"aedf26a6-bb0f-469d-9893-d5dd626fa00b","resolution":{"observed_at":"2026-08-05T14:25:35.703934Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.689970Z","title":"Lessons learned in empirical scoring with smina from the csar 2011 benchmarking exercise","venue":null,"work_id":"ca925905-debf-4649-ab6d-aa4a7a3fb0b3","year":2011},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":30,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:28.931506Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:f0b19499fdac933693bb575ef5f60fdfe5f7a2317681c2e20b6ac9e97077d511","observation_id":"80d40693-b026-462e-84f1-9895cea71a9e","resolution":{"observed_at":"2026-08-05T14:25:35.693739Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.679720Z","title":"A 3d generative model for structure-based drug design","venue":null,"work_id":"2f4c0978-91aa-4651-b455-019a4aaf313f","year":2021},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":31,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.043798Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:772eab8741f0f89dfd5303ea6ea27f5376bdceab87735ba1399d559b3823e115","observation_id":"78adbec1-0a09-401d-832d-bd35e2329254","resolution":{"observed_at":"2026-08-05T14:25:35.683320Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.669556Z","title":"Gnina 1.0: molecular docking with deep learning","venue":null,"work_id":"0dc1b1f6-7df1-4813-94ac-36e6c222e4b4","year":2021},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":32,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.127500Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:5aa51bfb62d932a94f6e26838cae00bf03a70417de4aa22270c89384057a1f81","observation_id":"76804ed2-7673-4633-aa5f-1b54f711b2a4","resolution":{"observed_at":"2026-08-05T14:25:35.673382Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.658115Z","title":"3d molecule generation by denoising voxel grids","venue":null,"work_id":"812c8891-b41f-4b99-a6f8-c209c7208cce","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":33,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.215327Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:d65d8ca09bdc361080f08533f0787c5202692266ab83da2d702979a9ff60cbf9","observation_id":"b03e1972-15a5-48d2-992e-ec8d8ccbcd94","resolution":{"observed_at":"2026-08-05T14:25:35.661728Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.537669Z","title":"Pocket2mol: Efficient molecular sampling based on 3d protein pockets","venue":null,"work_id":"d5735cda-a2b6-46e1-9b84-fc27cad1bae8","year":2022},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":34,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.285907Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:8c07dcbaa1923f44f9bec277488d1684cc5c121e80da5e2f3295e647cf4cb059","observation_id":"303244e1-558e-445b-8f24-694736762545","resolution":{"observed_at":"2026-08-05T14:25:35.608080Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2305.07508","last_updated":"2023-05-11T08:11:19Z","snapshot_observed_at":"2026-08-16T15:33:56.802351Z","submitted_at":"2023-05-11T08:11:19Z","title":"MolDiff: Addressing the Atom-Bond Inconsistency Problem in 3D Molecule Diffusion Generation","version":1},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2305.07508","snapshot_observed_at":"2026-08-05T14:25:29.394587Z","title":"Moldiff: Addressing the atom-bond inconsistency problem in 3d molecule diffusion generation","venue":null,"work_id":null,"year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":35,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.394587Z"},"links":{"cited_paper":"/paper/2305.07508","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:b7f7e1fd3d2cbdd8e5d7828eacfb9353e8ce3c865775813f711e97d3c0e28e1c","observation_id":"a3b8f302-f1bd-46a0-82f8-b76b8c1bb878","resolution":{"observed_at":"2026-08-05T14:25:29.394587Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.332675Z","title":"Geometric deep learning for structure-based ligand design","venue":null,"work_id":"bcd88a37-7f99-4d08-91cc-dccbd7f27483","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":36,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.483161Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:0ebac4da3f20bc796f48b34c1e5d075bdd63c15058a3688a6834a2ad522f4ea7","observation_id":"9bb84b3e-45aa-43dc-be7c-b462c49d6638","resolution":{"observed_at":"2026-08-05T14:25:35.419346Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:35.158526Z","title":"Molcraft: Structure-based drug design in continuous parameter space","venue":null,"work_id":"7afc4af4-e1ff-41dc-850e-65ba9177a45e","year":2024},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":37,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.597946Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:41ee44242aa77cc913ea79fdb00419ec9d78ed167cbcaf582def46ac25e63cb9","observation_id":"7229f47d-e83e-4b4f-9ddb-0d06fc7db79a","resolution":{"observed_at":"2026-08-05T14:25:35.243750Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:34.924636Z","title":"Generating 3d molecules con- ditional on receptor binding sites with deep generative models","venue":null,"work_id":"2099cb24-739d-4867-9cdb-a1ae521766db","year":2022},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":38,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.675003Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:3f8877fefbf4e8ea1941f76f5d7eedab3d1dda8b294fdfeb23d2fe26d5bf8158","observation_id":"40e7c504-d5ca-44ff-bb22-caf082a2701b","resolution":{"observed_at":"2026-08-05T14:25:35.043630Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:34.617259Z","title":"Structure-based drug design with equivariant diffusion models, 2023","venue":null,"work_id":"8000a88c-8094-42f3-9e14-6f5523640636","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":39,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.751063Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:47016485a0ec77e4b0c58dab8b7f2e80ec18db43692b124525fa4d3a2cbb5842","observation_id":"539b5194-2d31-4058-896d-677fa4aba21d","resolution":{"observed_at":"2026-08-05T14:25:34.748192Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:34.353848Z","title":"Structure-based drug design with equivariant diffusion models","venue":null,"work_id":"c99b178f-d821-40ab-bdc0-4b8241a9343e","year":2024},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":40,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.817784Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:96b45634564c5c1a2c7ea5daef282174fd83cf8e81740eaabedab3464e469e41","observation_id":"916f60f3-f3d0-4a6a-9a44-818136a284f7","resolution":{"observed_at":"2026-08-05T14:25:34.474999Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2203.09168","last_updated":"2022-04-01T07:01:22Z","snapshot_observed_at":"2026-08-16T17:13:52.206028Z","submitted_at":"2022-03-17T08:46:17Z","title":"On the Pitfalls of Heteroscedastic Uncertainty Estimation with Probabilistic Neural Networks","version":2},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2203.09168","snapshot_observed_at":"2026-08-05T14:25:29.931810Z","title":"On the pitfalls of heteroscedastic uncertainty estimation with probabilistic neural networks","venue":null,"work_id":null,"year":2022},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":41,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:29.931810Z"},"links":{"cited_paper":"/paper/2203.09168","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:930b82299fc2d37391dddf489bcbf550ad31e9a642ff60eed96483fc8c90c0b6","observation_id":"80e0e365-2cc7-4269-af1e-7514071941a0","resolution":{"observed_at":"2026-08-05T14:25:29.931810Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:34.142152Z","title":"Tacogfn: Target-conditioned gflownet for structure-based drug design","venue":null,"work_id":"d17eecca-adeb-431a-a76c-31826a473d37","year":null},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":42,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.047436Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:a58203c24693570712b2030e44de09b2e484da714ebd802492ad91ea6da38337","observation_id":"1b4e9a2e-f68c-40de-93cf-2055dd84b713","resolution":{"observed_at":"2026-08-05T14:25:34.226009Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2310.03223","last_updated":"2024-09-06T17:26:00Z","snapshot_observed_at":"2026-08-16T14:54:57.776871Z","submitted_at":"2023-10-05T00:45:04Z","title":"TacoGFN: Target-conditioned GFlowNet for Structure-based Drug Design","version":6},"cited_work":{"arxiv_id":"2310.03223","doi":null,"metadata_source":"pith","pith_arxiv_id":"2310.03223","snapshot_observed_at":"2026-08-05T14:25:31.649242Z","title":"TacoGFN: Target-conditioned GFlowNet for Structure-based Drug Design","venue":"cs.LG","work_id":"516af893-ea06-4164-8f10-c9068a709092","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":43,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.149222Z"},"links":{"cited_paper":"/paper/2310.03223","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:facd7865745914b1d7e862501b0068a3d28e8d21ba3f87038160af21fdb8920b","observation_id":"0a13d31b-cfbb-42b0-a166-11c282b495d3","resolution":{"observed_at":"2026-08-05T14:25:31.729773Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:33.956089Z","title":"From target to drug: generative modeling for the multimodal structure-based ligand design.Molecular pharmaceutics, 16(10):4282–4291, 2019","venue":null,"work_id":"daa9306c-272c-408d-ba03-fca25bcd92fb","year":2019},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":44,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.244844Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:f6f66c577e0835560a8637614ab558cba8d0e90565306487b116b3afc1cf3a4e","observation_id":"95c506fb-3ed8-416f-80e4-08e8f1cb836f","resolution":{"observed_at":"2026-08-05T14:25:34.031008Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2011.13456","last_updated":"2021-02-10T18:17:04Z","snapshot_observed_at":"2026-07-06T02:11:23.670680Z","submitted_at":"2020-11-26T19:39:10Z","title":"Score-Based Generative Modeling through Stochastic Differential Equations","version":2},"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":null,"pith_arxiv_id":"2011.13456","snapshot_observed_at":"2026-08-05T14:25:30.313220Z","title":"Score-based generative modeling through stochastic differential equations","venue":null,"work_id":null,"year":2011},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":45,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.313220Z"},"links":{"cited_paper":"/paper/2011.13456","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:c4fb217c00cccd440e86f1482428eddc51da1f7d664dbb56e5ff0d16daf4ab70","observation_id":"496a8d85-c63e-467f-a53e-0a3d90e1669c","resolution":{"observed_at":"2026-08-05T14:25:30.313220Z","resolver_source":null,"status":"unresolved"},"standing_notice":{"events":[],"reason":"canonical_work_link_unavailable","source_receipts":[],"state":"unavailable"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:33.790427Z","title":"Unified generative modeling of 3d molecules with bayesian flow networks","venue":null,"work_id":"5583c5ec-5f4a-4ef5-a22b-cd25e2048421","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":46,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.394275Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:fdbf9d5f6dac908322442fe4f7104a6761d607f7749ead510b50aa1141a0e40c","observation_id":"8e59c6ef-d98c-4cb6-a9ba-0f55e3d0338d","resolution":{"observed_at":"2026-08-05T14:25:33.873781Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:33.610587Z","title":"Selective optimization of side activities: another way for drug discovery","venue":null,"work_id":"c5c4d562-4c55-4331-b091-fd73115623db","year":2004},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":47,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.529703Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:d0b3001af61eca6046f01da3fddfc9f5f82c617df27d00b68d7390fc808ecb56","observation_id":"d1a15dbc-e954-4b4f-b6c3-59c202c6162e","resolution":{"observed_at":"2026-08-05T14:25:33.689922Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:33.440433Z","title":"Learning subpocket prototypes for generalizable structure-based drug design","venue":null,"work_id":"17617663-abe7-425a-800b-cc407859da90","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":48,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.627743Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:23e15b92d8a085b5c96760b958109f99a10c9415c6bb7522c01fc3c96ac5b4f0","observation_id":"61daa666-f283-4118-8a0d-e766d873e290","resolution":{"observed_at":"2026-08-05T14:25:33.508353Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:33.257467Z","title":"Molecule generation for target pro- tein binding with structural motifs","venue":null,"work_id":"df5ad24e-2e5b-4133-8c69-0ea9826ab8a6","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":49,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.699013Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:f3fefa1ec4af5496f6916ffa3ce34f5bdf003f214b11ec089ad94ef2a5441171","observation_id":"e3e189fc-c547-47ab-b1ad-4794fd956ab3","resolution":{"observed_at":"2026-08-05T14:25:33.348023Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":{"arxiv_id":"2306.11768","last_updated":"2024-11-16T02:51:56Z","snapshot_observed_at":"2026-08-16T15:22:32.387336Z","submitted_at":"2023-06-20T14:21:58Z","title":"Geometric Deep Learning for Structure-Based Drug Design: A Survey","version":6},"cited_work":{"arxiv_id":"2306.11768","doi":null,"metadata_source":"pith","pith_arxiv_id":"2306.11768","snapshot_observed_at":"2026-08-05T14:25:31.459329Z","title":"Geometric Deep Learning for Structure-Based Drug Design: A Survey","venue":"q-bio.QM","work_id":"397c9487-9cd3-4b72-b578-5ac3ed43abdf","year":2023},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":50,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.791122Z"},"links":{"cited_paper":"/paper/2306.11768","citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:3ca8f9bf6e8252599a3e172feb51207a5fdd01d9de932991f1de3cef99deee06","observation_id":"6fe4ccaf-4330-442b-ad39-5d0e1bbf8f94","resolution":{"observed_at":"2026-08-05T14:25:31.511955Z","resolver_source":"local_arxiv","status":"verified_exact"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:33.071207Z","title":"known unknown","venue":null,"work_id":"2064cb7e-ff58-4838-85c7-02fe3f0758ee","year":null},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":51,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.895618Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:86e9cddb379a7a7b9fe1ee6430d3d491086cda3b67ff7ee7d2b8cc108f4c54a6","observation_id":"473074fa-b053-4931-abec-30281d4c7a75","resolution":{"observed_at":"2026-08-05T14:25:33.150214Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:32.881306Z","title":null,"venue":null,"work_id":"c1850b3a-8155-4657-b02f-3b607397565e","year":null},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":52,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:30.963695Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:5e1d59558ae824df3278a8b6550348521d9e9a3175945c9e7111cad8ca5578ff","observation_id":"637c19c6-7dac-4ef8-8266-19a9b8d8e8d3","resolution":{"observed_at":"2026-08-05T14:25:32.974261Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:32.663817Z","title":null,"venue":null,"work_id":"6f1ac05f-a789-4307-90ed-6bcd22c124b9","year":null},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":53,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:31.071125Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:3c0629129d9a5a535adde0298ed4ba8a8bf7cf33794d439409dd45f43682a075","observation_id":"b0d98ba8-6690-423c-a925-0a37e10522d4","resolution":{"observed_at":"2026-08-05T14:25:32.799964Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:32.444134Z","title":"Here h(θi−1, yi, αi) computes the posterior parameter after observing yi with precision αi, given the prior θi−1","venue":null,"work_id":"72c73f6b-1840-4782-8bd4-7fc860166a5d","year":null},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":54,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:31.149120Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:7e6c8d6901469f7fa9b9b9fd11eea8857b60806fd9b9c09eaf9da9c5641d05b7","observation_id":"fdf75671-3e8e-4701-8255-57d0eea07636","resolution":{"observed_at":"2026-08-05T14:25:32.571158Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:32.269515Z","title":"In contrast, diffusion models explicitly add random noise to samples at each step to maintain stochasticity","venue":null,"work_id":"3a674c26-ac0d-4666-a9fe-f214542213ee","year":null},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":55,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:31.223917Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:fefdef55117c70eba785c635d43c04afc943f707067a1c756f80a1f4b36a1153","observation_id":"5c10dfd4-1644-4947-af80-d0435e69b56d","resolution":{"observed_at":"2026-08-05T14:25:32.356065Z","resolver_source":"raw_fallback","status":"verified_fuzzy"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:32.087246Z","title":null,"venue":null,"work_id":"5cdc22fa-bc2c-46bc-b129-608fc6be785a","year":null},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":56,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:31.300974Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:bd941a986f44e4a9b23f0d25b69e02eef62c3f50121b4060998f72c3d2b1ed85","observation_id":"66be65b3-41ec-4830-943a-e9d2bffc65f8","resolution":{"observed_at":"2026-08-05T14:25:32.178924Z","resolver_source":"raw_fallback","status":"unresolved"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}},{"citation":{"cited_paper":null,"cited_work":{"arxiv_id":null,"doi":null,"metadata_source":"raw_reference","pith_arxiv_id":null,"snapshot_observed_at":"2026-08-05T14:25:31.886167Z","title":"Only Generation Type","venue":null,"work_id":"b7920fd1-b886-4576-800c-2c2e0d8b6277","year":null},"citing_paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration","version":1},"reference_index":57,"source":"pdf_text","source_observed_at":"2026-08-05T14:25:31.339421Z"},"links":{"citing_paper":"/paper/2508.21468"},"observation_digest":"sha256:dda59b53cad20d02d28d7d207512647a7831c41d9de1614eb7f79061d1353b7c","observation_id":"36b354fe-8d4c-4f37-8624-acd9b4bddcb7","resolution":{"observed_at":"2026-08-05T14:25:31.976708Z","resolver_source":"raw_fallback","status":"malformed_identifier"},"standing_notice":{"events":[],"observation":"No event found in the named queried sources as of 2026-08-17T06:30:58.91139+00:00.","reason":null,"source_receipts":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"state":"measured"}}],"paper":{"arxiv_id":"2508.21468","last_updated":"2025-08-29T09:49:15Z","latest_version":1,"primary_category":"cs.LG","snapshot_observed_at":"2026-08-10T20:16:46.654314Z","submitted_at":"2025-08-29T09:49:15Z","title":"Controllable 3D Molecular Generation for Structure-Based Drug Design Through Bayesian Flow Networks and Gradient Integration"},"reference_resolution":{"displayed":57,"state_counts":{"malformed_identifier":1,"metadata_mismatch":0,"parse_uncertain":0,"unresolved":16,"verified_exact":2,"verified_fuzzy":38},"total_outbound_references":57},"refusal":"A citation records a reference. It does not transfer a finding from one paper to another.","schema":"pith.paper-citation-record.v1","standing_sources":[{"observed_at":"2026-08-17T06:30:58.91139+00:00","source":"crossref"},{"observed_at":"2026-08-17T06:30:54.323127+00:00","source":"retraction_watch"}],"thesis":"As of 18 August 2026, this Paper Citation Record lists 57 of 57 outbound references and 1 inbound Pith citation observation for arXiv:2508.21468."}